Relafen 750, structurally known as its salt form, offers a specific metabolic mckennaii pathway of action. From a pharmaceutical standpoint , it functions primarily as a anti-inflammatory agent , inhibiting cyclooxygenase enzymes – notably COX-1 and COX-2 – to alleviate pain and fever . The resulting decrease in inflammatory mediator synthesis